This was the stock's second consecutive day of gains.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.

Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

“Mathemalchemy” has been described as “a mathematics fever dream turned artistic playground for all math lovers (and haters, too).” ...

About 52 per cent of employees experience burnout due to poor work-life balance, showed a survey conducted in five states in ...

The investment round highlights investor interest in the crypto payment sector, which has gained traction in mainstream ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Hold rating on Caribou Biosciences (CRBU – Research Report), with a ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.